4-YEAR SURVIVAL-DATA OF PATIENTS WITH ADVANCED RENAL-CELL CARCINOMA TREATED WITH AUTOLOGOUS TUMOR VACCINE AND SUBCUTANEOUS ADMINISTRATION OF RECOMBINANT INTERLEUKIN-2 AND INTERFERON-ALPHA (2B)
S. Pomer et al., 4-YEAR SURVIVAL-DATA OF PATIENTS WITH ADVANCED RENAL-CELL CARCINOMA TREATED WITH AUTOLOGOUS TUMOR VACCINE AND SUBCUTANEOUS ADMINISTRATION OF RECOMBINANT INTERLEUKIN-2 AND INTERFERON-ALPHA (2B), European journal of cancer, 31A, 1995, pp. 44-44